|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.52 USD | +1.24% |
|
-5.18% | -2.11% |
| 07-09 | Teva Pharmaceuticals Obtains Rights to Commercialize Polpharma's Biosimilar Candidate to Ocrevus | MT |
| 07-09 | Teva, Samsung Bioepis Partner to Commercialize Eylea Biosimilar Opuviz in Canada | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.24% | -5.18% | -8.01% | -2.11% | -2.11% | +84.26% | +253.59% | +246.77% | -43.77% | 35.11B | |
| +1.71% | +1.32% | +7.00% | +29.09% | +10.23% | +48.28% | +157.90% | +385.19% | +1,344.97% | 1,037B | |
| +1.14% | +3.47% | +8.19% | +12.14% | +24.98% | +52.96% | +51.19% | +50.56% | +107.11% | 615B | |
| +1.40% | +1.01% | +9.45% | +27.87% | +12.45% | +34.85% | +79.46% | +117.40% | +299.48% | 448B | |
| +5.14% | +5.40% | +7.47% | +7.57% | +6.49% | +33.75% | +27.79% | +0.63% | +40.47% | 326B | |
| +1.85% | +3.57% | +3.44% | +9.79% | +16.48% | +37.09% | +40.59% | +50.95% | +55.30% | 293B | |
| -0.11% | +0.48% | -6.64% | -12.45% | -7.99% | +18.87% | +17.70% | +49.62% | +172.65% | 264B | |
| +0.25% | -4.62% | +4.08% | +29.83% | -1.52% | -27.66% | -41.76% | +12.21% | +72.90% | 216B | |
| +0.29% | -1.23% | +5.76% | +5.27% | +12.12% | +18.68% | +55.89% | +48.15% | +120.34% | 198B | |
| -0.23% | -4.61% | +3.97% | -2.71% | +5.93% | +14.49% | +67.42% | +88.37% | +46.83% | 162B | |
| +0.71% | -0.60% | +1.09% | -6.30% | +0.36% | -1.46% | -33.38% | -40.04% | -32.06% | 141B | |
| +1.46% | +1.69% | +10.80% | +4.25% | +14.07% | +25.62% | -4.94% | -9.96% | -18.57% | 124B | |
| +0.62% | -2.20% | +1.48% | +9.25% | +4.85% | -0.34% | +33.13% | +137.07% | +396.32% | 120B | |
| -0.62% | -0.75% | +3.93% | -6.60% | -7.69% | -9.79% | -22.22% | -13.30% | -0.20% | 105B | |
| -0.26% | -2.58% | -2.66% | -8.21% | +4.44% | +38.94% | +36.52% | +7.66% | -8.00% | 102B | |
| -1.29% | +1.18% | -4.12% | -17.67% | -12.51% | +6.36% | +79.99% | +74.75% | +454.77% | 73.72B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| -0.85% | +4.10% | +10.65% | +3.52% | +13.86% | +29.38% | +25.48% | +48.38% | +23.49% | 54.35B | |
| -0.87% | -4.50% | +11.24% | -0.96% | -7.82% | -4.35% | +19.55% | -10.39% | +251.42% | 53.93B | |
| -1.64% | -3.19% | +19.69% | +15.38% | +24.83% | +62.25% | -10.27% | -9.77% | -50.12% | 52.66B | |
| Average | +0.49% | +1.12% | +4.57% | +5.10% | +5.87% | +24.32% | +43.87% | +64.96% | +170.18% | 224.18B | |
| Weighted average by Cap. | +1.21% | +1.39% | +5.51% | +13.12% | +9.52% | +31.47% | +64.73% | +127.25% | +407.44% |
- Stock Market
- Stocks
- TEVA Stock
- Sector Teva Pharmaceutical Industries Limited
Select your edition
All financial news and data tailored to specific country editions
